 |
 |

Cutaneous Squamous Cell Carcinoma in Human Immunodeficiency Virus-Infected PatientsA Study of Epidemiologic Risk Factors, Human Papillomavirus, and p53 Expression
Toby A. Maurer, MD;
Kirsten Vin Christian, MD;
Russell L. Kerschmann, MD;
Bella Berzin, MD;
Joel M. Palefsky, MD;
Deborah Payne, PhD;
Stephen K. Tyring, MD;
Timothy G. Berger, MD
Arch Dermatol. 1997;133(5):577-583.
Abstract
 |  |
Objective To examine risk factors for the development of cutaneous squamous cell carcinoma (SCC) in a group of human immunodeficiency virus (HIV)— infected patients, including evaluation and detection of epidemiologic risk factors of human papillomavirus (HPV) and p53 expression.
Design Case-control study during a 3-year period.
Setting Dermatologic referral center.
Patients Thirty-three HIV-infected patients who had 97 SCCs were compared with 24 HIV-infected patients who had 70 basal cell carcinomas (BCCs).
Main Outcome Measures Age, skin type, amount of sun exposure, actinic damage, family history of skin cancer and history of smoking and warts. Specimens of SCC and BCC were examined for HPV using polymerase chain reaction. Presence of p53 was examined using immunohistochemical analysis. Specimens from tumor-free, non—sun-exposed areas from these same patients were used as controls.
Results Risk factors for the development of both types of carcinoma included fair skin type and excessive sun exposure (>6 h/d during the previous 10 years). The HIV-infected patients with SCCs tended to have outdoor occupations. The location of SCCs favored the head and neck; BCCs were located on the trunk. Patients with SCCs had later-stage HIV disease than did patients with BCCs. Half of the patients with SCC had a history of genital or nongenital warts. Seventy-one percent (17/24) had a smoking history. No statistical difference existed between patients with SCCs and BCCs for history of smoking or warts. Human papillomavirus was not found in most of our SCC, BCC, or control specimens. However, 92% (22/24) of the SCC specimens and 90% (18/20) of the BCC specimens stained for p53. Control specimens from non—sun-exposed skin of HIV-infected patients did not stain for p53. Epidermal staining was present in 95% (17/20) of tissue adjacent to SCCs and 47% (7/15) of tissue adjacent to BCCs. A significantly positive correlation existed between the amount of sun exposure and the amount of p53 staining seen in adjacent epidermal tissue (r=0.07; P=.01).
Conclusions Risk factors for the development of SCCs and BCCs in HIV-infected patients are similar: fair skin type and excessive sun exposure. Our study does not support that HPV is an oncogenic factor in the development of these cutaneous tumors but provides evidence that p53 overexpression may play a role.
Arch Dermatol. 1997;133:577-583
Author Affiliations
From the Departments of Dermatology (Drs Maurer, Vin Christian, and Berger), Pathology (Dr Kerschmann), and Laboratory Medicine (Dr Palefsky), University of California, San Francisco; Department of Internal Medicine, Kaiser Foundation Hospital, Santa Clara, Calif (Dr Berzin); and the Department of Microbiology, University of Texas Medical Branch, Galveston (Drs Payne and Tyring).
CiteULike Connotea Del.icio.us Digg Reddit Technorati Twitter
What's this?
THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES
Cutaneous Malignancies Among HIV-Infected Persons
Crum-Cianflone et al.
Arch Intern Med 2009;169:1130-1138.
ABSTRACT
| FULL TEXT
Skin Lesions: Mirror Images of Oral Lesion Infections
Phanuphak
ADR 2006;19:69-72.
ABSTRACT
| FULL TEXT
Aggressive Squamous Cell Carcinomas in Persons Infected With the Human Immunodeficiency Virus
Nguyen et al.
Arch Dermatol 2002;138:758-763.
ABSTRACT
| FULL TEXT
Altered Clinical Course of Malignant Melanoma in HIV-Positive Patients
Rodrigues et al.
Arch Dermatol 2002;138:765-770.
ABSTRACT
| FULL TEXT
Association of Cancer With AIDS-Related Immunosuppression in Adults
Frisch et al.
JAMA 2001;285:1736-1745.
ABSTRACT
| FULL TEXT
|